SOW
TXMD icon

State of Wyoming’s TherapeuticsMD TXMD Stock Holding History

State of Wyoming’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,797
Closed -$58K – 1764
2022
Q3 		$58K Buy
8,797
+5,865
+200% +$47.5K 0.03% 937
2022
Q2 		$29K Sell
2,932
-372
-11% -$3.55K 0.02% 1283
2022
Q1 		$63K Buy
3,304
+1,750
+113% +$27.5K 0.03% 922
2021
Q4 		$28K Buy
+1,554
New +$46.6K 0.01% 1379

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State of Wyoming's TXMD Position: Q4 2022 in Review

State of Wyoming sold out of TherapeuticsMD (TXMD) in Q4 2022, closing a stake of 8,797 shares — an estimated $58K sold.

State of Wyoming first reported a position in TXMD in Q4 2021 and held it in 4 quarters. The position peaked at $63K in Q1 2022. 44 funds tracked by Wall St. Rank hold TXMD as of Q4 2022.

  • State of Wyoming reported no remaining TherapeuticsMD position as of Q4 2022 after selling out during the quarter.
  • State of Wyoming sold 8,797 TherapeuticsMD shares in Q4 2022, an estimated $58K.
  • State of Wyoming first reported a position in TherapeuticsMD in Q4 2021 and held it in 4 quarters.
  • State of Wyoming's TherapeuticsMD position peaked at $63K in Q1 2022.
  • 44 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2022.

Based on State of Wyoming's 13F filing for Q4 2022, filed 15 Feb 2023.